New Topical Drug Delivery System Pharmaceutical Organogel: A Review
DOI:
https://doi.org/10.22270/ajprd.v10i1.1088Keywords:
Organogel, advantage, disadvantage, classification, properties, applicationsAbstract
A simple working definition of this term'Gel' is a soft, durable or solid material,containing both solids and liquid parts, where the solid part(gelator) exists as amesh / network of aggregates, viz immobilize part of the liquid,a strong network prevents the liquid from leaking flow, especially by local pressure. The gel is called a hydrogel or Organogel depending on the type liquid component: water in hydrogel and a living solvent in organogels .Organogels have been discovered as a multipurpose tool in pharmaceuticals for topical as well as transdermal delivery of various drugs. They are semisolid classifications consists of apolar phase and a solid phase. Gels are form through the mechanism of entrapment of a polar segment into the three-dimensional networked assembly of solid phase. Apolar phase is inculded as a solvent such as isopropyl palmitate, isopropyl myristate etc.an organogelator such as sorbiatanmonostearte, lecithin etc. are consist by solid phase Organogel, non-crystalline, nonglassythermoreversible (thermoplastic)solid materials and viscoelastic system,can be considered semi-solid an immobilized preparation external apholar phase. Apholar the section closes between spaces of a three-dimensional network a structure built due to physical condition negotiation between collectors compound properties considered as gelators. Generally, these programs are supported in structurant integration molecules .These systems are good transporter for both hydrophilic and lipophilic therapeutic agents. The present review describes a number of important properties of organogel, different types of organogel based on organogelator, method of preparation and various applications in pharmaceuticals.
Downloads
References
2. Dhiman S, Singh GT, Rehni AK. Transdermal patches: a recent approach to new drug delivery system. Int J Pharm Pharm Sci 2011;3:26–34.
3. Sharma C, Agrawal D, Goyal R, Sharma AK, Khandelwal M, Organogel : A new approach in topical drug delivery system, European Journal of Pharmaceutical And Medical Research 8(11):304-307.
4. A introduction to hydrogels and some resent application by Mortezabahram, Namieshmohseni Moghtadar submitted october 20 /2015 ,reviewed 18/may/2016 ,published 24/ aug/2016.
5. R.Gupta , M.K. Gupta, and H.K Sharma, ―A Review on Organogels and Fluid Filled Method‖ International Journal of Scientific Research and Reviews 2014:280- 282.
6. Prakash T. Sangale and GadhaveManoj V, ― Organogel: A Novel approach for Transdermal Drug Delivery System‖ World Journal of Pharmaceutical Research 2014; 427-428.
7. Kumar, R. and O.P. Katare, Lecithin Organogels as a Potential Phospholipid-Structured System for Topical Drug Delivery: A Review. AAPS PharmSciTech, 2005; 298-310.
8. Schurtenberger, P., et al., Structural and dynamic properties of polymer-like reverse micelles. The Journal of Physical Chemistry, 1990: 3695-3701.
9. Swati C. Jagdale, Priya S. Khawale, Bhanudas S. Kuchekar, and Aniruddha R. Chabukswar, ―Development and Evaluation of Pluronic Lecithin Organogel Topical Delivery of Tapentadol‖ American Journal of Pharmaceutical Sciences and Nanotechnology, 2015.
10. Veena S Belgamwar, Mohit S Pandey, Dhiraj S Chauk, Sanjay J Surana, ―Pluronic lecithin organogel ‖ Asian Journal of Pharmaceutics 2008; 134-135.
11. GargTarun, Bilandi Ajay, Kapoor Bhawana, Kumar Sunil, ― Organogel: Advance and Novel drug delivery‖ International Research Journal of Pharmacy. Nov-2011 pp:3-4
12. Nigar Kadar Mujawar*, SangramsinhLaxmanGhatage And Veerendra C. Yeligar, ―Organogel: Factors And Its Importance‖ International Journal of Pharmaceutical, Chemical and Biological Sciences. 2014 ; 764-766.
13. Hongzhuo Liu, Yongjun Wang, Fei Han, Huimin Yao, Sanming Li, ―Gelatin-StabilisedMicroemulsion-Based Organogels Facilitates Percutaneous Penetration of Cyclosporin A In Vitro and Dermal Pharmacokinetics In Vivo‖ Wiley Inter Science. Dec-2006; 3001
14. GargTarun, Bilandi Ajay, Kapoor Bhawana, Kumar Sunil, ― Organogel: Advance and Novel drug delivery‖ International Research Journal of Pharmacy. 2011; 3-4
15. Varsha Gupta, MeenuNagpal, Imran Khan, Geeta Aggarwal, Rupinder Kaur, Sukhdev Singh, TapanBehl, Mehta et al. / Indian J. Pharm. Biol. Res., 2016; 4(3):28-37 Review Article 37
16. Upendra Kumar Jain, ―A Review On Non-Ionic Surfactant Based Organogel For Transdermal Delivery ‖ World Journal of Pharmacy and Pharmaceutical Sciences .2014; 3[ 9]:154.
17. S. Kantaria, G. D. Rees and M. J. Lawrence, J. Control. Rel. 1999; 60, 355.
18. K. K. Upadhyay, C. Tiwari, A. J. Khopade, H. B. Bohidar and S. K. Jain, Drug Dev. Ind. Pharm. 2007; 33:617.
19. Agrawal D, Goyal R, Bansal M, Sharma AK, Khandelwal M, Development And Evaluation Of Econazole Organogel; International Journal of Current Pharmaceutical Review and Research., 13(2), Pages: 15-23.
20. Sharma A K, Naruka P S, Soni S, Khandelwal M, Shaneza A, Sharma M, Development And Evaluation Of Hydrogel of Kitoconazole; International Journal of Current Pharmaceutical Review and Research., Aug. 2019; 11(3):01-11.
21. Sharma A K, Naruka P S, Soni S, Sarangdewot YS, Khandelwal M, Shaneza A, Formulation, Development And Evaluation of Luliconazole Hydrogel; International Journal of Current Pharmaceutical Review and Research., Nov. 2018; 10(4):01-06.
22. Rajkapoor Balasubramanian, Abdussalam A Sughir, Goupale Damodar, ―Oleogel: A promising base for transdermal formulations‖ Asian Journal of Pharmaceutics 2012; 5-7.
23. B.V. Mikari, K.R.Mahadik, Formulation and evaluation of topical liposomal gel for fluconazole. S.A. Korde, Indian J .Pharm.Sci., 2010. 44(4), 324-325.
24. Rupal Jani, Kaushal Jani, Setty C.Mallikarjuna, Preparation and evaluation of topical gel Valdecoxib. Dipti Patel, Inter.journal.Pharm.Sci. Research. 2010; 2(1):51-54.
25. Shah VP: Transdermal drug delivery system regulatory issues. In: Guy R.H. and had graft J. (eds.), Transdermal drug delivery. Marcel Dekker, New York, 2003; 361-367.
26. Carter SJ: Disperse system In: Cooper and Gunn’s Tutorial Pharmacy. 6th ed. New Delhi: CBS Publishers and Distributors; 2000: 68-72.
Published
How to Cite
Issue
Section
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).